title: [Clinical efficacy of reamberin in drug-addicts with hepatic lesions].
abstract: Infusion of 1.5% reamberin solution was shown to be a safe tool for combined therapy of severe viral hepatitis in drug addicts with signs of polyorganic lesions. Reamberin had detoxicating, antioxidative, hepato- and nephroprotective effects associated with clinical improvement, reduced hospital stay and normalized biochemical characteristics. Moreover, it increased the serum antioxidative potential and non-specific resistance of the patients.
authors.forename: V A
authors.initials: VA
authors.lastname: Isakov
authors.forename: G S
authors.initials: GS
authors.lastname: Arkhipov
authors.forename: V V
authors.initials: VV
authors.lastname: Turkin
authors.forename: I V
authors.initials: IV
authors.lastname: Aleksandrov
mesh_terms: D000293:Adolescent; D000328:Adult; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy*; D006509:Hepatitis B / Q000188:drug therapy*; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D008536:Meglumine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D009293:Opioid-Related Disorders / Q000150:complications*; D013386:Succinates / Q000008:administration & dosage / Q000494:pharmacology*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: C549374:Reamberin; D013386:Succinates; D008536:Meglumine